Viewing StudyNCT00146276



Ignite Creation Date: 2024-05-05 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 9:14 AM
Study NCT ID: NCT00146276
Status: UNKNOWN
Last Update Posted: 2006-09-27
First Post: 2005-09-02

Brief Title: Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer
Sponsor: Association of Urologic Oncology AUO
Organization: Association of Urologic Oncology AUO

Organization Data

Organization: Association of Urologic Oncology AUO
Class: OTHER
Study ID: B9E-MC-S062
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Association of Urologic Oncology AUO
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Eli Lilly and Company INDUSTRY